These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 19020731)

  • 1. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
    Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
    Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
    Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
    Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
    Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial thioredoxin and thioredoxin reductase as mediators for epigallocatechin 3-gallate-induced antimicrobial action.
    Liang W; Fernandes AP; Holmgren A; Li X; Zhong L
    FEBS J; 2016 Feb; 283(3):446-58. PubMed ID: 26546231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase.
    Wang X; Tian W
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1200-6. PubMed ID: 11700039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid rafts mediate epigallocatechin-3-gallate- and green tea extract-dependent viability of human colon adenocarcinoma COLO 205 cells; clusterin affects lipid rafts-associated signaling pathways.
    Pajak B; Kania E; Gajkowska B; Orzechowski A
    J Physiol Pharmacol; 2011 Aug; 62(4):449-59. PubMed ID: 22100846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antifolate activity of tea catechins.
    Navarro-Perán E; Cabezas-Herrera J; García-Cánovas F; Durrant MC; Thorneley RN; Rodríguez-López JN
    Cancer Res; 2005 Mar; 65(6):2059-64. PubMed ID: 15781612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of CYP1A by green tea extract in human intestinal cell lines.
    Netsch MI; Gutmann H; Schmidlin CB; Aydogan C; Drewe J
    Planta Med; 2006 May; 72(6):514-20. PubMed ID: 16773535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological response of rhesus monkey kidney epithelial cells exposed to epigallocatechin-3-gallate.
    Vance SH; Tucci M; Benghuzzi H
    Biomed Sci Instrum; 2005; 41():223-8. PubMed ID: 15850109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
    Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
    Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation.
    Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M
    Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
    Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
    Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
    J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
    Gorlatov SN; Stadtman TC
    Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.
    El Bedoui J; Oak MH; Anglard P; Schini-Kerth VB
    Cardiovasc Res; 2005 Aug; 67(2):317-25. PubMed ID: 15885676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
    Banerjee T; Sharma SK; Surolia N; Surolia A
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
    Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
    Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.